$ERAS
Erasca, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ERAS down today? It is at $17.12 (-5.26%), and our scanner flagged it 277 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ERAS spikes, and full due diligence on ERAS — key stats, earnings, dilution and insider activity. Free.
Get free $ERAS alerts the moment volume spikes
Our scanner flagged $ERAS 277 times in the last 30 days. Create a free account to track $ERAS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $17.12
- Change today
- -5.26%
- Previous close
- $18.07
- 52-week range
- $1.33 – $24.28
- Market cap
- $6.33B
- Total held
- 13.1%
- Tradeable float
- 303.9M 87% of shares · after 13% insiders + institutional n/a
- Short interest
- 30.0M ▼ -3% vs prior · as of 2026-07-31
- Short % of float
- 9.9%
- Days to cover
- 7.3d
- Avg daily volume
- 4.6M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.3x
- 1h
- 0.7x
- 1D
- 0.2x
Get free ERAS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ERAS down today?
ERAS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on ERAS today, peaking at 14.8x its normal volume.
Likely catalystErasca, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Aug 17, 2026 · 3 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
0 buys, 0 sells last 3 months (2/3 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Garner Ebun Officer | Sold (automatic/other) | -80K 0.02% of company | sold 76% | 25K | $1.3M at $16.40 | Apr 1, 26 |
Garner Ebun Officer | Other | 80K 0.02% of company | added 100% | 105K | $136K at $1.70 | Apr 1, 26 |
Morris Shannon Officer | Sold (automatic/other) | -20K | n/a | n/a | $301K at $15.04 | Mar 4, 26 |
Morris Shannon Officer | Other | 20K | n/a | 20K | $34K at $1.70 | Mar 4, 26 |
Garner Ebun Officer | Sold (automatic/other) | -120K 0.03% of company | sold 83% | 25K | $671K at $5.59 | Jan 7, 26 |
Garner Ebun Officer | Other | 120K 0.03% of company | added 100% | 145K | $204K at $1.70 | Jan 7, 26 |
Garner Ebun Officer | Acquired (grant/award) | +4K | added 18% | 25K | $5K at $1.19 | Dec 15, 25 |
Chacko David M. Officer | Acquired (grant/award) | +18K | added 6.8% | 280K | $21K at $1.19 | Dec 15, 25 |
Multani Pratik S Director | Sold (automatic/other) | -6K | sold 3.6% | 167K | n/a | May 23, 25 |
Multani Pratik S Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | May 23, 25 |
Garner Ebun Officer | Acquired (grant/award) | +6K | added 37% | 21K | $9K at $1.56 | Dec 13, 24 |
Chacko David M. Officer | Acquired (grant/award) | +12K | added 4.9% | 262K | $19K at $1.56 | Dec 13, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $ERAS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 4,714,285 new shares · Priced at $17.5/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ERAS Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ERAS Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to ERAS
Comparable names in pharmaceutical preparations, closest in size first.
ERAS stock FAQ
Why is $ERAS down today?
ERAS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on ERAS today, peaking at 14.8x its normal volume.
What is the ERAS stock price today?
ERAS last traded at $17.12, down 5.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ERAS alerts?
The ERAS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ERAS 277 times in the last 30 days.
What exchange is ERAS on?
ERAS (Erasca, Inc. Common Stock) trades on XNAS, with a market cap of about $6.33B in the PHARMACEUTICAL PREPARATIONS sector.
Is ERAS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ERAS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.